1. Empagliflozin for heart failure with preserved ejection fraction: targeting cardiac endothelial cell-cardiomyocyte interaction. (July 2018) Authors: Juni, R.; Kuster, D.W.D.; Goebel, M.; Helmes, M.; van der Velden, J.; Musters, R.; Koolwijk, P.; Paulus, W.; van Hinsbergh, V. Journal: Journal of molecular and cellular cardiology Issue: Volume 120(2018)Supplement Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗